Bayesian Capital Management, LP Gilead Sciences, Inc. Transaction History

Bayesian Capital Management, LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $1.16 Million - $1.41 Million	16,200 New	16,200 $1.19 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $4.52 Million - $4.93 Million	61,100 New	61,100 $4.58 Million
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $2.19 Million - $2.49 Million	28,300 New	28,300 $2.35 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $559,676 - $639,294	9,400 New	9,400 $580,000
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $2.3 Million - $2.61 Million	-35,400 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $2.4 Million - $2.59 Million	35,400 New	35,400 $2.47 Million
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $3.25 Million - $3.7 Million	-54,100 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $1.51 Million - $1.72 Million	26,700 Added 97.45%	54,100 $3.15 Million
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $1.7 Million - $2.14 Million	27,400 New	27,400 $1.73 Million
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $781,896 - $860,060	-12,689 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$62.51 - $69.0 $793,189 - $875,541	12,689 New	12,689 $804,000
Q4 2017 Feb 12, 2018	SELL	$71.15 - $83.52 $1.09 Million - $1.28 Million	-15,300 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $1.1 Million - $1.31 Million	15,300	15,300 $1.24 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.